Medtronic Cardiovascular — Accelerated amortization decreased by 34.8% to $30.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase signals potential product obsolescence or a strategic decision to phase out certain technologies.
This represents the non-cash charge taken when the carrying value of an intangible asset in the cardiovascular segment i...
Comparable to impairment or accelerated amortization charges in the technology-heavy segments of medical device companies.
mdt_segment_cardiovascular_accelerated_amortization| Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $45.00M | $46.00M | $30.00M |
| QoQ Change | — | +2.2% | -34.8% |